Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
Sircoulomb F, Nicolas N, Ferrari A, Finetti P, Bekhouche I, Rousselet E, Lonigro A, Adélaïde J, Baudelet E, Esteyriès S, Wicinski J, Audebert S, Charafe-Jauffret E, Jacquemier J, Lopez M, Borg JP, Sotiriou C, Popovici C, Bertucci F, Birnbaum D, Chaffanet M, Ginestier C. Sircoulomb F, et al. Among authors: jacquemier j. EMBO Mol Med. 2011 Mar;3(3):153-66. doi: 10.1002/emmm.201100121. Epub 2011 Feb 15. EMBO Mol Med. 2011. PMID: 21328542 Free PMC article.
Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rougé C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyriès S, Adélaïde J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M. Gelsi-Boyer V, et al. Among authors: jacquemier j. Mol Cancer Res. 2005 Dec;3(12):655-67. doi: 10.1158/1541-7786.MCR-05-0128. Mol Cancer Res. 2005. PMID: 16380503
Prognosis and gene expression profiling of 20q13-amplified breast cancers.
Ginestier C, Cervera N, Finetti P, Esteyries S, Esterni B, Adélaïde J, Xerri L, Viens P, Jacquemier J, Charafe-Jauffret E, Chaffanet M, Birnbaum D, Bertucci F. Ginestier C, et al. Among authors: jacquemier j. Clin Cancer Res. 2006 Aug 1;12(15):4533-44. doi: 10.1158/1078-0432.CCR-05-2339. Clin Cancer Res. 2006. PMID: 16899599
Integrated profiling of basal and luminal breast cancers.
Adélaïde J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, Charafe-Jauffret E, Cervera N, Desplans J, Parzy D, Schoenmakers E, Viens P, Jacquemier J, Birnbaum D, Bertucci F, Chaffanet M. Adélaïde J, et al. Among authors: jacquemier j. Cancer Res. 2007 Dec 15;67(24):11565-75. doi: 10.1158/0008-5472.CAN-07-2536. Cancer Res. 2007. PMID: 18089785
How different are luminal A and basal breast cancers?
Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Buttarelli M, Jacquemier J, Chaffanet M, Maraninchi D, Viens P, Birnbaum D. Bertucci F, et al. Among authors: jacquemier j. Int J Cancer. 2009 Mar 15;124(6):1338-48. doi: 10.1002/ijc.24055. Int J Cancer. 2009. PMID: 19058218
Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.
Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaïde J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R. Bertucci F, et al. Among authors: jacquemier j. Hum Mol Genet. 2002 Apr 15;11(8):863-72. doi: 10.1093/hmg/11.8.863. Hum Mol Genet. 2002. PMID: 11971868
Identification and validation of an ERBB2 gene expression signature in breast cancers.
Bertucci F, Borie N, Ginestier C, Groulet A, Charafe-Jauffret E, Adélaïde J, Geneix J, Bachelart L, Finetti P, Koki A, Hermitte F, Hassoun J, Debono S, Viens P, Fert V, Jacquemier J, Birnbaum D. Bertucci F, et al. Among authors: jacquemier j. Oncogene. 2004 Apr 1;23(14):2564-75. doi: 10.1038/sj.onc.1207361. Oncogene. 2004. PMID: 14743203
331 results